HCPCS Procedure & Supply Codes →
Temporary Procedures & Professional Services →
section notes
Quality Reporting Codes →
section notes
Measure Groups for Quality Payment Program →
section notes
G8633‑G9769   Measures 400-499
G9341‑G9763   Measures 300-399
G9497‑G9645   Measure 404: Anesthesiology Smoking Abstinence
G9511‑G9511   Measure 411: Depression Remission at Six Months
G9529‑G9533   Measure 415: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older
G9537‑G9537   Measure 419: Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination
G9539‑G9544   Measure 421: Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal
G9552‑G9556   Measure 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients
G9580‑G9767   Measure 413: Door to Puncture Time for Endovascular Stroke Treatment
G9593‑G9597   Measure 416: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years
G9603‑G9605   Measure 420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey
G9606‑G9608   Measure 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury
G9609‑G9611   Measure 423: Perioperative Anti-platelet Therapy for Patients Undergoing Carotid Endarterectomy
G9621‑G9624   Measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
G9625‑G9627   Measure 432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair
G9628‑G9630   Measure 433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair
G9637‑G9638   Measure 436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques
G9646‑G9648   Measure 409: Clinical Outcome Post Endovascular Stroke Treatment
G9649‑G9765   Measure 410: Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
G9654‑G9773   Measure 424: Perioperative Temperature Management
G9655‑G9658   Measure 426: Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU)
G9659‑G9661   Measure 439: Age Appropriate Screening Colonoscopy
G9662‑G9782   Measure 438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
G9683‑G9685   Measure 414: Evaluation or Interview for Risk of Opioid Misuse
G9775‑G9777   Measure 430: Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy
G9784‑G9784   Measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time – Pathologist to Clinician
G9787‑G9797   Measure 441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
G9805‑G9807   Measure 443: Non-Recommended Cervical Cancer Screening in Adolescent Females
G9812‑G9813   Measure 445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)
G9818‑G9821   Measure 447: Chlamydia Screening and Follow Up
G9822‑G9824   Measure 448: Appropriate Workup Prior to Endometrial Ablation
G9830‑G9832   Measure 450: Trastuzumab Received By Patients With AJCC Stage I (T1c) – III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy
G9838‑G9841   Measure 451: KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
G9842‑G9845   Measure 452: Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies
G9846‑G9847   Measure 453: Proportion Receiving Chemotherapy in the Last 14 Days of Life
G9858‑G9861   Measure 457: Proportion Admitted to Hospice for less than 3 days
G9943‑G9943   Measure 459: Average Change in Back Pain following Lumbar Discectomy / Laminotomy
G9946‑G9946   Measure 460: Average Change in Back Pain following Lumbar Fusion
G9954‑G9958   Measure 463: Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)
G9959‑G9961   Measure 464: Otitis Media with Effusion (OME): Systemic Antimicrobials- Avoidance of Inappropriate Use
G9962‑G9963   Measure 465: "Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries"
G9964‑G9965   Measure 466: Well-child Visits
demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.